Determination of Bendroflumethiazide in Plasma by High Performance Liquid Chromatography and Fluorescence Detection
- 1 October 1986
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 9 (13) , 2937-2943
- https://doi.org/10.1080/01483918608074160
Abstract
An accurate, precise, and specific assay is described for the determination of bendroflumethiazide (BFTZ) in plasma. The procedure employs a C18 column, a mobile phase consisting of 35% acetonitrile in 0.015M phosphoric acid, and a fluorescence detector with a 254nm excitation filter and a 400nm emission filter. Furosemide is used as the internal standard. Using lml of plasma, this method can detect 10ng/ml of BFTZ.This publication has 5 references indexed in Scilit:
- Application of conventional (DC) and differential pulse polarography (DPP) to the quality control of benzothiadiazines in tablets. Simultaneous determination of hydrochlorothiazide and dihydralazine sulphate in mixtures with minimization of interaction byJournal of Pharmacy and Pharmacology, 1982
- Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazineEuropean Journal of Clinical Pharmacology, 1982
- Semiaqueous Potentiometric Determinations of Apparent pKa1 Values for Benzothiadiazines and Detection of Decomposition during Solubility Variation with pH StudiesJournal of Pharmaceutical Sciences, 1981
- Extractive alkylation of sulphonamide diuretics and their determination by electron-capture gas chromatographyJournal of Chromatography A, 1979
- A GLC assay for bendroflumethiazide. Preliminary data about its plasma level in manEuropean Journal of Clinical Pharmacology, 1976